Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas
Clinical trial NCT00453427 · COMPLETED
Trial details
- NCT number
- NCT00453427
- Sponsor
- Ontario Clinical Oncology Group (OCOG)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2013-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.